Exploring the Impact of VR-based Acupuncture Treatment on Patient Experience and Doctor-patient Interaction.
Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Sep 30, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new approach to acupuncture treatment using virtual reality (VR). The focus is on how this VR-based method can improve the overall experience of patients receiving acupuncture and enhance the interactions between patients and doctors. Researchers aim to understand if using VR can make acupuncture more effective and enjoyable for individuals seeking treatment.
To participate in this trial, you should be part of the general public or someone who visits an acupuncture clinic. However, if you prefer not to try the virtual reality aspect of acupuncture, you won't be eligible to join. While the trial is not yet recruiting participants, those who do take part can expect to experience acupuncture treatment in a new and innovative way, potentially leading to better outcomes and communication with their healthcare providers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • general public and people see a doctor in the department of acupuncture
- Exclusion Criteria:
- • participant refusing the intervention of the virtual reality
About China Medical University Hospital
China Medical University Hospital is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. Affiliated with China Medical University, the hospital is renowned for its comprehensive approach to medical education and research, fostering collaboration between healthcare professionals and academic experts. With state-of-the-art facilities and a commitment to ethical standards, the hospital conducts rigorous clinical trials aimed at improving treatment outcomes across various medical disciplines, contributing significantly to both local and global healthcare advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported